News
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 23, 2023
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company working to revolutionize care through the development of potentially best-in-class regenerative therapeutics,...
-
Mar 21, 2023
Independent Studies Validate Enhanced Clinical Grade Cell Production for Patient Use in Multiple Indications at a Fraction of Current Industry Cost PHOENIX, March 21, 2023 /PRNewswire/ -- Creative...
-
Feb 8, 2023
Company reaches next clinical trial milestone for treatment of Type 1 Diabetes with the first novel allogenic cellular therapy in the dorsal artery of the pancreas in the United States PHOENIX,...
-
Nov 3, 2022
AlloStem™ represents the first novel allogenic cellular therapy in the dorsal artery of the pancreas in the United States PHOENIX, Nov. 3, 2022 /PRNewswire/ -- Creative Medical Technology...
-
Oct 20, 2022
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, neurology, and orthopedics,...